Orla Mining Ltd.
ORLAAbout the company
Orla Mining Ltd. acquires, explores, develops, and exploits mineral properties. It explores gold, silver, zinc, lead, and copper deposits. The company owns 100% interests in the Camino Rojo project that consists of seven concessions covering an area of 138,636 hectares located in Zacatecas, Mexico; Cerro Quema project totaling an area of 15,000 hectares located in the Azuero Peninsula, Panama; and the South Railroad project consisting of an area of 21,000 hectares located in Elko, Nevada. It also holds interest in acquisition of the Musselwhite Gold Mine project located in Ontario, Canada.
Investment snapshot
Positive
5
BUY / PASS
Neutral / negative
3 / 8
NEUTRAL / FAIL
Median fair value
$6.12
-35.2% vs price
Models with upside
4 / 17
Positive margin of safety
Strongest signal
9 of 10 pass — Sleep objects
Key risk
9 of 12 flag ORLA's debt & leverage — Graham, Buffett, Lynch +6 more
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | NEUTRAL | BUY · Rank #100 (Top 3.2%) | FAIL | NEUTRAL | PASS | FAIL | PASS | FAIL | BUY | PASS | PASS | FAIL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Margin of Safety | -161.5% | +40.3% | -72.9% | -39.4% | N/A | -293.3% | +82.5% | +19.1% | N/A | -472.1% | +88.3% | -493.7% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2025 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 · Market data at 2026-10-01 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 · Market data at 2026-10-01 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-10-01 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-10-01 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-20 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-10-01 Latest source filing: 2026-03-20 Score computed: 2026-11-14 |
Where It Passes
- Cash Flow90% pass✓ 11✗ 1▾
9 of 10 pass — Sleep objects
Free Cash Flow Proxy$217.5M✓BuffettPositive and growingFCF Positive and Growing$768.2M✓LynchPositive and growingOperating Cash Flow$803.3M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=38.65%, ROA=5.14%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)4.0x✓Dreman< 8xP/E or FCF YieldP/E=31.5x, FCF Yield=21.7%✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive4/7 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap23.9%✓Ackman>= 4%Price / FCF per Share4.2x✓Ackman<= 25Positive Operating Cash Flow frequency4/7 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$768.2M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+21.68%; #269/4519 (top 6.0%)✓OshaughnessyTop 10% of eligible cross-section
Where It Falls Short
- Debt & Leverage25% pass✓ 6✗ 9▾
9 of 12 flag ORLA's debt & leverage — Graham, Buffett, Lynch +6 more
LT Debt vs Net Current AssetsLT Debt $335.7M vs NCA $41.3M✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.54, IC: 27.4x✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.54✗Lynch< 0.33Cash - Long-term Debt$85.0M✓LynchPositive preferredLT Debt / Total Assets Change0.00% -> 16.15%✗PiotroskiDecreased YoYCurrent Assets / Current Liabilities1.08✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.54✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.54✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=27.4x, D/EBITDA=0.5x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.54✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.5422; #2551/4210 (top 60.6%)✗AsnessTop 30% of eligible cross-section - Valuation31% pass✓ 8✗ 20▾
9 of 13 flag ORLA's valuation — Graham, Lynch, Dreman +6 more
Price / 3-yr avg EPS59.0x✗Graham<= 15xPrice-to-Book Ratio4.9x✗Graham<= 1.5xP/E x P/B288.70✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)1.73✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value17.8%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=17.8%, ROC=64.3%✓GreenblattBoth EY > 10% and ROC > 25%Price / EPS31.5x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)4.0x✓Dreman< 8xPrice / Book Value per Share4.9x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=31.5x, OE Yield=6.8%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=31.5x, FCF Yield=21.7%✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=31.5x, P/B=4.9x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-293.3% (IV=$2.40 vs Price=$9.44)✗Marks>= 20% below intrinsic valuePrice / FCF per Share4.2x✓Ackman<= 25Price vs. Trailing Low153% of trailing low ($6.17)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization+3.02%; #2369/6340 (top 37.4%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.1852; #4253/6449 (top 65.9%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS31.5x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share4.89x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+168.2%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.2986; #3338/5247 (top 63.6%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+21.68%; #269/4519 (top 6.0%)✓OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-27.94%; #4325/6202 (top 69.7%)✗OshaughnessyTop 10% of eligible cross-section - Valuation models40% pass✓ 4✗ 6▾
Models split on ORLA at $9.44 — fair values range $1.59–$80.91
Graham fair value$3.61✗Graham-161.5% margin vs $9.44Buffett fair value$15.80✓Buffett+40.3% margin vs $9.44Lynch fair value$5.46✗Lynch-72.9% margin vs $9.44Greenblatt fair value$6.77✗Greenblatt-39.4% margin vs $9.44Dreman fair value$2.40✗Dreman-293.3% margin vs $9.44Munger fair value$53.87✓Munger+82.5% margin vs $9.44Pabrai fair value$11.67✓Pabrai+19.1% margin vs $9.44Marks fair value$1.65✗Marks-472.1% margin vs $9.44Ackman fair value$80.91✓Ackman+88.3% margin vs $9.44Templeton fair value$1.59✗Templeton-493.7% margin vs $9.44 - Verdicts43% pass✓ 6✗ 8▾
Split decision: 8 FAIL · 4 PASS · 3 NEUTRAL · 1 BUY
Overall verdict✗GrahamFAIL (1/9)✗BuffettFAIL (3/9)•LynchNEUTRAL (5/7)✓GreenblattRank #100✗PiotroskiFAIL (F-Score 3)•DremanNEUTRAL (7/11)✓MungerPASS (2/4)✗PabraiFAIL (1/3)✓AkrePASS (3/6)✗MarksFAIL (2/5)✓AckmanBUY (9/9)✓TempletonPASS (4/8)✓SleepPASS (3/6)✗AsnessFAIL (Rank #1490/2370 (Top 62.9%))✗NeffFAIL (3/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked) - Profitability44% pass✓ 17✗ 18▾
9 of 16 flag ORLA's profitability — Graham, Buffett, Lynch +6 more
Positive EPS (10 years)5/8 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)23.1%✗Graham>= 33% growthNet Income Positive (10+ years)3/8 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)4.9%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$217.5M✓BuffettPositive and growingEarnings Variance (10-yr CoV)0.86✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)1.73✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR18.2%✓Lynch15-30% (Fast Grower); > 0% to passROE16.3%✓Lynch> 15%EBIT / Enterprise Value17.8%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=17.8%, ROC=64.3%✓GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets5.14%✓PiotroskiROA > 0ROA Change YoY14.87% -> 5.14% (delta: -9.73%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=38.65%, ROA=5.14%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY63.3% -> 53.2%✗PiotroskiImproved YoYPre-Tax Income / Revenue24.7%✓Dreman>= 8%Net Income / Shareholders' Equity16.3%✓Dreman> 12%Margin of SafetyP/E=31.5x, P/B=4.9x✗PabraiP/B < 1.5 or P/E < 15Return on Equity9.0% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic Value-293.3% (IV=$2.40 vs Price=$9.44)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency3/7 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue58.5%✓Ackman>= 15%Net Income / Shareholders Equity16.3%✓Ackman>= 15%5-Year EPS CAGR18.2% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend21.1% (2023) -> 58.5% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 60.6% -> 53.2%, operating margin 21.1% -> 58.5%✓SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization+3.02%; #2369/6340 (top 37.4%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+27.05%; #1586/3702 (top 42.8%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+16.29%; #1043/5226 (top 20.0%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0817; #3228/5884 (top 54.9%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR18.2% over 5 years✓Neff7%-20% annualizedPositive Diluted-EPS Years5/6 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Growth50% pass✓ 9✗ 4▾
4 of 8 pass — Graham, Lynch, Marks +1 more object
EPS Growth (3-yr avg, 10-yr window)23.1%✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)1.73✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR18.2%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 193.4% vs Rev: 207.6%✓LynchInventory growth < Revenue growthEPS Growth Direction$0.13 (2020) -> $0.30 (2025)✓DremanPositive over recent yearsEPS CAGR18.2% CAGR over 5 years✓Dreman> 5% annualizedPositive Net Income Frequency3/7 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth47.2%✓Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR18.2% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 60.6% -> 53.2%, operating margin 21.1% -> 58.5%✓SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR18.2% over 5 years✓Neff7%-20% annualized - Efficiency50% pass✓ 6✗ 5▾
4 of 8 pass — Graham, Piotroski, Dreman +1 more object
Current Ratio1.08✗Graham>= 2.0ROIC (3-5 yr avg)46.5%✓Buffett> 10%ROIC - WACC+36.5%✓BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)64.3%✓Greenblatt> 25%Current Ratio Change YoY3.97 -> 1.08✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.57x -> 0.51x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities1.08✗Dreman> 1.5Return on Invested Capital48.3%✓Munger> 15%ROIC (high and growing)FY2023: ROIC=8.0%; FY2024: ROIC=32.1%; FY2025: ROIC=48.3%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC48.3% (RR=100% x ROIC=48.3%)✓AkreReinvestment Rate * ROIC > 10%ROIC (5-year)2/3 years above 12% (latest 48.3%)✓SleepROIC > 12% in a majority of years
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Issued 5.7% of shares last year, 8.0% issued over two.
- Buybacks
- —
- Dividends
- —
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|
| Market Cap | $3.5Bcurrent | $2.0Best. | $1.1Best. | $1.3Best. | $809.7Mest. |
| Revenue | $1.1B↑208% | $343.9M↑47% | $233.6M↑21% | $193.2M↑4585% | $4.1M |
| Operating Income | $618.5M↑199% | $206.8M↑319% | $49.4M | -- | -- |
| Net Income | $106.9M↑20% | $89.0M↑429% | -$27.0M↓159% | $45.8M↑274% | -$26.3M |
| EPS (Diluted) | $0.30↑11% | $0.27↑400% | $-0.09↓156% | $0.16↑45% | $0.11 |
| Gross Margin | 53.2%↓16% | 63.3%↑4% | 60.6%↓8% | 66.2% | 66.3% |
| Operating Margin | 58.5%↓3% | 60.1%↑184% | 21.1% | — | — |
| ROE | 16.3%↓7% | 17.5%↑360% | -6.7%↓158% | 11.5%↑181% | -14.2% |
| Total Debt | $355.7M↑16226% | $2.2M↓98% | $88.3M↓39% | $145.8M↓10% | $161.4M |
| Shareholders' Equity | $656.2M↑29% | $507.4M↑27% | $400.5M↑1% | $397.0M↑115% | $184.4M |
| Current Ratio | 1.08↓73% | 3.97↓22% | 5.07↑273% | 1.36↑6% | 1.28 |
| Debt / Equity | 0.54↑12526% | 0.00↓98% | 0.22↓40% | 0.37↓58% | 0.87 |
| Operating Cash Flow | $803.3M↑360% | $174.6M↑167% | $65.3M↓31% | $95.3M↑485% | -$24.7M |
| Free Cash Flow | $768.2M↑385% | $158.5M↑177% | $57.1M↓36% | $89.6M↑419% | -$28.0M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Precious Metals
ORLA vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AGNICO EAGLE MINES LTDAEM | $90.2B | $178.45 | $11.9B | $4.5B | 18.0% | 0.01 | — | 2.02 | 3/9 | 5/9 | 5/7 | 1/3 | F-Score 9 | 5/11 |
| BARRICK MINING CORPB | $61.2B | $37.59 | $17.0B | $5.0B | 18.8% | 0.17 | — | 2.92 | 3/9 | 5/9 | 7/7 | 3/3 | F-Score 9 | 5/11 |
| GOLD FIELDS LTDGFI | $31.6B | $35.76 | $5.2B | $1.2B | 23.9% | 0.48 | — | — | 2/9 | 3/9 | 5/7 | 0/3 | F-Score 5 | 6/11 |
| KINROSS GOLD CORPKGC | $24.5B | $20.76 | $7.1B | $2.4B | 27.9% | 0.09 | 46.5% | 2.35 | 4/9 | 5/9 | 7/7 | 3/3 | F-Score 9 | 9/11 |
| PAN AMERICAN SILVER CORPPAAS | $15.5B | $37.50 | $3.6B | $980.0M | 14.0% | 0.10 | 34.1% | 2.69 | 3/9 | 2/9 | 4/7 | 0/3 | F-Score 7 | 5/11 |
| Coeur Mining, Inc.CDE | $14.3B | $13.98 | $2.1B | $585.9M | 17.7% | 0.02 | 34.2% | 2.47 | 2/9 | 2/9 | 2/7 | 1/3 | F-Score 6 | 4/11 |
| Equinox Gold Corp.EQX | $12.3B | $10.31 | $1.8B | $221.5M | 3.8% | 0.27 | 23.8% | — | 2/9 | 2/9 | 3/7 | 0/3 | F-Score 6 | 2/11 |
| ALAMOS GOLD INCAGI | $12.0B | $28.61 | $1.8B | $885.8M | 19.9% | 0.04 | 60.7% | 2.00 | 4/9 | 2/9 | 7/7 | 0/3 | F-Score 8 | 7/11 |